For example, UCA1 can induce acquired resistance to EGFR-tyrosine kinase inhibitors (TKIs) in EGFR-mutant nonsmall cell lung cancer by activating the AKT/mTOR pathway [44]. This evidence concerns the gene EGFR and lung cancer.